RAPT FY 2022 Earnings — RAPT Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

RAPTRAPT Therapeutics, Inc.

$959M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-60.0% YoY

Gross Profit

$2M100.0% margin

Operating Income

-$86M-5618.5% margin

Net Income

-$84M-5490.4% margin

EPS (Diluted)

$-20.61

Cash Flow

Operating Cash Flow

-$71M

Free Cash Flow

-$72M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$266M

Total Liabilities

$21M

Stockholders' Equity

$245M

Cash & Equivalents

$39M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$4M	-60.0%
Gross Profit	$2M	$4M	-60.0%
Operating Income	-$86M	-$69M	-24.0%
Net Income	-$84M	-$69M	-21.1%